Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
DIRAS3 is a member of the ras superfamily, and is expressed in normal ovarian and breast epithelial cells, but not in ovarian and breast cancers. Zusätzlich bieten wir Ihnen DIRAS3 Proteine (5) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 40 products:
Human Polyclonal DIRAS3 Primary Antibody für ELISA, WB - ABIN563932
Li, Ramani, Sun, Zee, Grant, Yang, Xia, Oh, Ko, Mato, Lu: Forced expression of methionine adenosyltransferase 1A in human hepatoma cells suppresses in vivo tumorigenicity in mice. in The American journal of pathology 2010
polymorphism-based approach was used to detect the imprinting status of NNAT (zeige NNAT Antikörper) and DIRAS3 genes in five heterozygous pigs (based on SNP) of Large White and Meishan F(1) hybrids
DiRas3 binds to KSR1 (zeige KSR1 Antikörper) independently of its interaction with activated Ras and RAF (zeige RAF1 Antikörper).
We demonstrate that DIRAS3 knock-down (KD) in adipose stromal/progenitor cells (ASCs) induces activation of Akt (zeige AKT1 Antikörper)-mTOR (zeige FRAP1 Antikörper) signaling and proliferation arrest. DIRAS3 KD ASCs lose the potential to form colonies and are negative for Ki-67 (zeige MKI67 Antikörper). Moreover, silencing of DIRAS3 results in a premature senescence phenotype.
ARHI-mediated up-regulation of glycolysis and glutaminolysis was found to be autophagy-dependent and inhibition of these metabolic pathways resulted in decreased cell viability.
The overexpression of ARHI promotes colon cancer SW480 cell apoptosis by inhibiting the level of Akt (zeige AKT1 Antikörper).
Transcriptional, but not post-transcriptional, silencing of GNG12-AS1 (zeige PTGDR Antikörper) causes concomitant upregulation of DIRAS3, indicating a function in transcriptional interference.
ARHI mRNA and protein expression is markedly decreased in osteosarcoma MG-63 cells lines. Overexpression of ARHI inhibits cell viability and proliferation.
ARHI-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.
EZH2 (zeige EZH2 Antikörper)-''induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in epithelial ovarian cancer
ARHI competes with RanGTPase and interacts with importin beta (zeige KPNB1 Antikörper) via basic-acidic patch interaction, which leads to inhibition of STAT3 (zeige STAT3 Antikörper) translocation.
Letter: ARHI suppresses pancreatic cancer by regulating ERK 1 (zeige MAPK3 Antikörper)/2 signaling.
This gene is a member of the ras superfamily, and is expressed in normal ovarian and breast epithelial cells, but not in ovarian and breast cancers. It is an imprinted gene, with monoallelic expression of the paternal allele, which is associated with growth suppression. Thus, this gene appears to be a putative tumor suppressor gene whose function is abrogated in ovarian and breast cancers.
DIRAS family, GTP-binding RAS-like 3
, GTP-binding protein Di-Ras3
, GTP-binding RAS-like protein 3
, distinct subgroup of the Ras family member 3
, ras homolog gene family, member I
, rho-related GTP-binding protein RhoI